[{"address1": "Wagistrasse 14", "city": "Schlieren", "zip": "8952", "country": "Switzerland", "phone": "41 44 755 77 00", "fax": "41 44 755 77 07", "website": "https://www.molecularpartners.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Molecular Partners AG, a clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland. Its product pipeline comprises MP0317, which is in Phase 1 clinical trial for the treatment of advanced solid tumors; MP053, novel tetra-specific T cell-engaging DARPin, which is phase 1 clinical trial for the treatment of acute myeloid leukemia; and MP0712, a 212Pb Radio-DARPin therapy (RDT) candidate targeting the tumor-associated protein delta-like ligand 3 (DLL3) which is in preclinical trial to treat SCLC and neuroendocrine tumors. It also researches for Switch-DARPin T cell engager to treat CD3 x costim x; and Radio-DARPin Therapy to treat ovarian disease. In addition, the company develops MP0621, a molecular partners' first Switch-DARPin program, which is in preclinical trial designed to induce killing of hematopoietic stem cells (HSCs) as a next-generation conditioning regimen for HSC transplantation (HSCT); and Radio-DARPin Therapy (RDT) platform, a delivery system for effective and selective delivery of radioactive payloads to solid tumors. It has collaboration agreement with Orano Med SAS to develop novel Radio-DARPin therapeutics and an additional six targeted alpha therapeutics candidates. Molecular Partners AG was incorporated in 2004 and is headquartered in Schlieren, Switzerland.", "fullTimeEmployees": 158, "companyOfficers": [{"maxAge": 1, "name": "Dr. Patrick  Amstutz Ph.D.", "age": 49, "title": "Co-Founder, CEO, Member of Management Board & Director", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 807078, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael Tobias Stumpp Ph.D.", "age": 52, "title": "Co-Founder, Executive VP of Projects & Member of Management Board", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Hendriks", "title": "Senior VP of Finance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alexander  Zurcher", "age": 49, "title": "COO & Member of Management Board", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Renate  Gloggner", "age": 54, "title": "Executive VP of People & Community and Member of Management Board", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Philippe  Legenne M.B.A., M.D.", "age": 58, "title": "Chief Medical Officer & Member of the Management Board", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Steiner Ph.D.", "title": "Senior Vice President of Research & Technology", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Seth D. Lewis", "title": "Senior Vice President of Investor Relations, Communications & Strategy", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Pitzner", "title": "General Counsel, Compliance Officer, Senior VP Legal & Business Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Pamela A. Trail Ph.D.", "age": 68, "title": "Strategic Consultant", "yearBorn": 1956, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.52, "open": 3.59, "dayLow": 3.47, "dayHigh": 3.59, "regularMarketPreviousClose": 3.52, "regularMarketOpen": 3.59, "regularMarketDayLow": 3.47, "regularMarketDayHigh": 3.59, "payoutRatio": 0.0, "beta": 0.546, "forwardPE": -1.8858695, "volume": 2606, "regularMarketVolume": 2606, "averageVolume": 1780, "averageVolume10days": 1050, "averageDailyVolume10Day": 1050, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 131002216, "fiftyTwoWeekLow": 3.36, "fiftyTwoWeekHigh": 7.6, "priceToSalesTrailing12Months": 58.69275, "fiftyDayAverage": 3.69844, "twoHundredDayAverage": 4.516155, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -12955996, "profitMargins": 0.0, "floatShares": 11386426, "sharesOutstanding": 36874600, "sharesShort": 31504, "sharesShortPriorMonth": 33745, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.00090000004, "heldPercentInsiders": 0.0, "heldPercentInstitutions": 0.09731, "shortRatio": 27.78, "shortPercentOfFloat": 0.0018000001, "impliedSharesOutstanding": 37752800, "bookValue": 3.841, "priceToBook": 0.90341055, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -59489000, "trailingEps": -2.11, "forwardEps": -1.84, "enterpriseToRevenue": -5.805, "enterpriseToEbitda": 0.214, "52WeekChange": -0.46615386, "SandP52WeekChange": 0.15005577, "quoteType": "EQUITY", "currentPrice": 3.47, "targetHighPrice": 17.148882, "targetLowPrice": 4.4472003, "targetMeanPrice": 10.727662, "targetMedianPrice": 10.657283, "recommendationKey": "none", "numberOfAnalystOpinions": 4, "totalCash": 130907000, "totalCashPerShare": 3.922, "ebitda": -60566000, "totalDebt": 2141000, "quickRatio": 15.046, "currentRatio": 15.276, "totalRevenue": 2232000, "debtToEquity": 1.67, "revenuePerShare": 0.064, "returnOnAssets": -0.23531, "returnOnEquity": -0.40095, "grossProfits": -43089000, "freeCashflow": -36099500, "operatingCashflow": -59279000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -27.554209, "financialCurrency": "CHF", "symbol": "MOLN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "regularMarketChangePercent": -1.4204532, "regularMarketPrice": 3.47, "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1623850200000, "postMarketChangePercent": 1.7291, "postMarketPrice": 3.53, "postMarketChange": 0.0599999, "regularMarketChange": -0.049999952, "regularMarketDayRange": "3.47 - 3.59", "exchange": "NMS", "messageBoardId": "finmb_32677064", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "longName": "Molecular Partners AG", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1780, "fiftyTwoWeekLowChange": 0.11000013, "fiftyTwoWeekLowChangePercent": 0.032738134, "fiftyTwoWeekRange": "3.36 - 7.6", "fiftyTwoWeekHighChange": -4.13, "fiftyTwoWeekHighChangePercent": -0.5434211, "fiftyTwoWeekChangePercent": -46.615387, "earningsTimestamp": 1756152000, "earningsTimestampStart": 1756152000, "earningsTimestampEnd": 1756152000, "earningsCallTimestampStart": 1741345140, "earningsCallTimestampEnd": 1741345140, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -2.11, "epsForward": -1.84, "epsCurrentYear": -1.60838, "priceEpsCurrentYear": -2.1574504, "fiftyDayAverageChange": -0.22844005, "fiftyDayAverageChangePercent": -0.061766595, "twoHundredDayAverageChange": -1.0461547, "twoHundredDayAverageChangePercent": -0.23164722, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-06-16", "cryptoTradeable": false, "shortName": "Molecular Partners AG", "corporateActions": [], "postMarketTime": 1755288250, "regularMarketTime": 1755288000, "trailingPegRatio": null, "__fetch_time": "2025-08-16"}]